Document is current
Any future updates will be listed below
-
Authors
Martins, Guilherme da Silva https://orcid.org/0009-0004-2680-4282
Rambo, Carolina https://orcid.org/0009-0009-3309-8693
Spessatto, Gabriela https://orcid.org/0009-0002-1220-3545
Saab, Maitê Milagres https://orcid.org/0009-0006-9172-1568
João, Bruno Hernandes David https://orcid.org/0009-0008-2383-0011
Fajardo, Aline Didoni https://orcid.org/0000-0003-4388-1541
Primon, Juliana Gonçalves https://orcid.org/0009-0009-0913-3663
Picciani, Thalita Gonçalves https://orcid.org/0000-0002-6426-9450
da Cunha, Roberta Corrêa https://orcid.org/0000-0001-7406-5286
Chong-Neto, Herberto José https://orcid.org/0000-0002-7960-3925
Massignan, Carlos Roberto Lebarbenchon https://orcid.org/0009-0004-9332-8394
Silva-Filho, Luiz Vicente Ribeiro Ferreira da https://orcid.org/0000-0001-8431-1997
Riedi, Carlos Antônio https://orcid.org/0000-0002-6044-3327
Filho, Nelson Augusto Rosário https://orcid.org/0000-0002-8550-8051
Chong-Silva, Débora Carla https://orcid.org/0000-0002-7385-4598
- License Information
-
More Information
This article is maintained by: Elsevier
Article Title: Efficacy and safety of using Elexacaftor/Tezacaftor/Ivacaftor in the treatment of children with cystic fibrosis: real-world evidence from Brazil
Journal Title: Jornal de Pediatria
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.jped.2025.05.007
Content Type: article
Copyright: © 2025 The Authors. Published by Elsevier España, S.L.U. on behalf of Sociedade Brasileira de Pediatria.
